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HIGHLIGHTS 
C57BL/6J mice demonstrated low anxiety in a 3-dimensional maze. 
Dizocilpine produced a high level of anxiety over 7 test sessions. 
Three days pre-training under saline prevented dizocilpine to produce anxiety. 
In pre-trained mice, dizocilpine produced sustained non-habituating hyperactivity. 
 
 
 
ABSTRACT 
Familiarity can imply a reduction of fear and anxiety, which may render learning and memory 
performance insensitive to NMDA receptor antagonism. Our previous study indicates that MK-
801 (dizocilpine), NMDA antagonist, increased anxiety and prevented the acquisition of a 
spatial memory task. Here, weexaminedwhetherMK-801 will produce anxiety in mice that were 
familiar with the test environment. 
Male C57BL/6J mice were exposed, one session a day for 7 days, to a 3D maze, which 
consisted of nine arms attached to upward inclined bridges radiating from a nonagonal 
platform. In this maze, high anxiety mice avoid the arms in the first sessions. One group of 
mice received saline (SAL) while a second group received MK-801 (MKD1), both on day one. A 
third group received saline in the first 3 sessions, and MK 801 in subsequent sessions (MKD4). 
Saline and MK-801 (0.1 mg/kg) were administered intraperitoneally 30 min before the test. 
MKD4 mice demonstrated an increase in bridge and arm visits, and reached arm/bridge entries 
ratio close to 1 in session 5. SAL mice also crossed frequently onto the arms, and reached a 
comparable ratio, but this was achieved with a lower number of arm visits. MKD1 mice 
demonstrated a reduced number of arm visits in each session compared to SAL and MKD4 
mice. 
Dizocilpine produced anxiety in mice treated from day 1 of the test, but not in those treated 
from day 4. It also impaired habituation in animals familiar with the test environment; it 
produced sustained non-habituating hyperactivity. 
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1. Introduction 
The first evidence of the role of NMDA receptor in spatial memory using the water maze [67] 
was challenged in subsequent research studies in which familiarity with the test environment 
appeared to prevent the impairing effects of NMDA antagonists [9,10,14,58,70,81,85,87,88, 
92,100]. This effect of familiarization was shown to occur in other behavioral conditioning 
paradigms [14,81,85,97,111,118]. However, familiarity can imply a reduction of fear and 
anxiety, which may render learning and memory performance insensitive to NMDA receptor 
antagonism. 
When exposed for the first time to a radial arm maze, mice and rats explore the proximal and 
avoid venturing into the distal segment of an arm. In the 3D maze (Fig. 1), which is a 
modification of the classic radial maze [69], animals need to climb onto an upwardly inclined 
bridge (proximal segment) attached to a central platform in order to access an arm (distal 
segment). During the first sessions, mice and rats were observed to reach the end of a bridge, 
then withdraw and return to the central platform; they do not continue into an arm. This 
avoidance of the distal segment, which is reflected by a low number of arm entries, is used as 
an indicator of fear and anxiety in mice. C57BL/6J and CD-1 mice demonstrated low anxiety 
compared to BALB/c J mice [28]. The latter made one or no visits during the first 3 sessions 
and required 5 sessions to make 8 arm visits whereas C57BL/6J and CD-1 mice made 8 arm 
visits in the second and third session, respectively. Repeated exposures to the test apparatus 
can lead to a reduction in anxiety. Hence, the arm/bridge entries ratio increase progressively 
to approach 1; this indicates that animals are no longer hesitant to cross onto the arms. The 
hesitation responses, which are indicated by a low arm/bridge entries ratio, reflect fear and 
anxiety in animals that have yet to make more than eight arm visits. They can also reflect 
impaired learning and memory performance in animals that had already made more than eight 
arm visits. 
 
2.2. Drug treatment 
Following 2 weeks acclimatization to the husbandry conditions, all mice were food-deprived, 
but had water ad libitum, and kept at 85±90% of their pre-test body weight throughout 
testing. They were randomly assigned to three groups (n = 8 per group) using a computer 
generated randomization software [QuickCalcs, GraphPad Software, Inc., La Jolla, CA]. The 
first group (SAL) received saline while the second group (MKD1) received MK-801 (0.1 mg/kg). 
The third group (MKD4) received saline in the first 3 days then MK-801 (0.1 mg/kg) in the 
remaining 4 days. Each group received intraperitoneal injection of its respective treatment 30 
min before each test session, one session a day for 7 days. MK-801 (Sigma, UK) was dissolved 
in normal saline (0.9% NaCl). It was freshly prepared, and administered in a volume of 0.1 ml 
per 10 g body weight of mice. 
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2.3. Apparatus 
The maze (Fig. 1) was made from grey PVC (5mmthick). It consisted of nine arms (35 cm × 
11.2 cm, each) connected to bridges (15.2 cm × 11.2 cm, each) radiating from a nonagonal 
shaped central platform. Mice can access an arm by crossing a bridge. The bridges can be level 
with the arms providing a standard radial maze configuration. They can also be tilted upward 
or downward providing a maze with a raised or a lowered arm configuration, respectively. A1 
cm diameter food well was located 1.5 cm from the end of each arm. Underneath this well, and 
separated by a small grid, there was another food well (3 cm diameter and 1 cm deep) 
containing inaccessible fresh food pellets. All parts of the maze apparatus were unprotected; 
hence, mice were exposed to a complete open space. In the present experiment, the bridge to 
each arm formed a slope, which was inclined upward by about 40°. The floor of the bridges 
was covered with wire-mesh grid, which can be easily removed for cleaning or swapped places. 
Each entry to a bridge was narrowed either on the left or on the right side by short wire mesh 
wall (width 5 cm × height 5 cm). The narrowing of the entries in and exits from the bridges 
were designed to prevent mice relying on sequential arm visits. In this setting, most mice did 
not choose more than one adjacent arm in a test session. The end of each arm was extended 
with panels of identical size (20.2 × 11.2 cm). These panels were used for holding intra-maze 
cues made of distinctive pattern drawings designed on plastic adhesive material and attached 
to a PVC board (18 × 11.2 cm). The maze was surrounded by a heavy pale beige-colored 
curtain, and it was placed in a sound attenuated room with a masking white noise of 68 dB. 
The illumination on the surface of the central platform was 180 Lux. 
 
 
Figure 1. Picture of a 9-arms 3-Dimensional maze 
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2.4. Test procedure 
Behavioral testing was conducted between 09:00 h and 15:00 h. All mice received their 
respective treatment in a counterbalanced order 30 min before each test session. A mouse was 
removed from its cage and placed in a small plastic beaker in which it was weighed. After an 
i.p. injection of saline or dizocilpine, a mouse was returned to its home cage where it was left 
for 30 min, then transported in the beaker to the test apparatus. The beaker was tilted gently 
over the central platform of the maze for the release of the mouse. In each test session, mice 
were left to explore for 10 min, and each food well contained a single food pellet [20 mg, 
Precision Pellets, Bio-Serv, UK] and was not replenished once depleted. During the test, mice 
were observed on a screen monitor connected to a video camera suspended above the test 
arena. Using an in-house computer program [EventLog] we recorded in sequential order the 
start and end of each entry to the different parts of the maze. This record provided a variety of 
measures including frequency, latency, duration, and the sequence order of each visit to the 
bridges and arms of the maze. An entry onto a bridge or an arm was recorded whenever a 
mouse crossed with all four paws the line that delimits these areas. After each test, the surface 
of the platform was cleaned to minimize the effects of lingering olfactory cues. Any feces and 
urine on the maze were removed with paper towels, then cleaned with ethanol, and left to dry 
before the introduction of the next mouse. 
 
2.5. Statistical analysis 
This was performed using Statistica [StatSoft Inc., Tulsa, OK]. All data are presented as mean 
and standard error of the mean (±SEM). Differences among group mean values for each 
measurement were tested for significance with two-way ANOVA, with group as a between- and 
sessions as within-subjects factors. This was followed up with Newman-Keuls post-hoc 
comparisons. Results were considered significant when p 0.05.When p N 0.05 and p 0.10, 
the p value was reported as nonsignificant, and rounded up to the nearest value. 
 
3. Results  
3.1. Latency to first bridge and arm entry 
Overall ANOVA revealed significant differences between groups [F2,21= 13.95 and 46.71 
respectively, p<0.0001] and between sessions [F6,126= 7.40 and 6.16 respectively, 
p<0.0001] for both parameters, and significant interactions between groups and sessions for 
the latency to the first arm [F12,126= 2.55, p<0.005] but not to the first bridge [F12,126= 
0.80, p>0.10] entry. Post-hoc comparisons indicates that MKD1 took longer time to cross for 
the first time onto a bridge compared to SAL and to MD4 in sessions 2-7 [p<0.01, Fig. 2A]. 
MKD1 took also a longer time to cross for the first time onto an arm compared to SAL [p<0.02, 
Fig. 2B] and to MKD4 [p<0.05, Fig. 2B]. 
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Figure 2. Latency of first entry on a bridge (A) and on an arm (B) of the maze. All data are 
shown as means ± SEM; n=8 in each group. (A) xcompared to SAL and to MKD4 [p<0.01]; 
(B) xcompared to SAL and to MKD4 [p<0.0002]; ³compared to SAL and to MKD4 [p<0.02]; 
­compared to SAL and to MKD4 [p<0.05].  
 
3.2. Total number of bridge and arm entries, and arm/bridge entries ratio 
Overall ANOVA revealed significant differences between groups [F2,21= 14.23, 69.98 and 
121.61, respectively, p<0.001], between sessions [F6,126= 4.11, 51.42 and 63.05 
respectively, p<0.0001] and significant interactions between groups and sessions [F12,126= 
6.42, 11.92 11.92 and 6.40 respectively, p<0.0001]. Post-hoc comparisons [Fig. 3A] revealed 
that in session 1, MKD1 made fewer bridge entries than SAL and MKD4 [p<0.003] whereas in 
sessions 4-6, they made more bridge entries than SAL [p<0.04]. In sessions 4-7, MKD4 made 
more bridge crossings than SAL [p<0.002] and MKD1 [p<0.001]. Post-hoc comparisons [Fig. 
3B] also show that MKD1 made fewer entries onto the arms than SAL [p<0.005] and MKD4 
[p<0.0002] in sessions 1-7, and MKD4 made more entries than SAL [p<0.007] in sessions 4-
7. The arm/bridge entries ratio [Fig. 3C] was significantly low in MKD1 compared to SAL 
[p<0.003] and to MKD4 [p<0.001] in each test session. There were no significant differences 
between saline and MKD4 groups [p>0.10]. 
 
 
  
x 
x 
x x x * 
x x x 
­ 
x 
³ 
x 
­ ­ ­ 
­ 
³ x x x 
h 
 
h 
 
h 
 
h 
 
³ ³ ³ ³ ³ 
³ ³ 
A B 
A B 
Physiology & Behavior 164 (2016) 353±360 
7 
 
 
Figure 3. Number of entries on the bridges (A), the arms (B) of the maze, and bridge arm 
entries ratio (C). All data are shown as means ± SEM; n=8 in each group.  (A) ³compared to 
SAL and MKD4 [p<0.003]; xcompared to SAL [p<0.04]; ­compared to SAL [p<0.002] and 
MKD1 [p<0.001]. (B) ³compared to SAL [p<0.005] and to MKD4 [p<0.0002]; hcompared to 
SAL [p<0.007] (C) ³compared to SAL [p<0.003] and to MKD4 [p<0.001].  
 
 
3.3. Total time spent on the bridges and on the arms of the maze, and arms/bridges ratio 
Overall ANOVA revealed significant differences between groups [F2,21= 16.60,  88.89, and 
33.12 respectively, p<0.0001], between sessions [F6,126= 52.58, 46.60 and 47.77 
respectively, p<0.001] and significant interactions between groups and sessions [F12,126= 
2.00, 5.71 and 7.05 respectively, p<0.03]. Post-hoc comparisons show that the time spent on 
the bridges [Fig. 4A] was significantly high in sessions 2 to 7 in MKD1 compared to SAL and 
MKD4 [p<0.05]. The time spent on the arms [Fig. 4B] was however lower in MKD1 than in the 
two other groups in session 1 [p<0.02] and sessions 2 to 7 [p<0.002]. The arms/bridges time 
ratio [Fig. 4C] was significantly low in MKD1 compared to SAL and MKD4 in sessions 2-7 
[p<0.005]. 
 
  
³ ³ ³ 
³ ³ 
³ 
³ 
x x 
x x x x 
³ ­ ­ 
­ ­ 
­ 
­ 
A B 
Physiology & Behavior 164 (2016) 353±360 
8 
 
 
Figure 4. Time spent on the bridges (A), the arms (B) of the maze, and bridge/arm time ratio 
(C). All data are shown as means ± SEM; n=8 in each group. (A) xcompared to SAL and MKD4 
[p<0.05]; (B) ³compared to MKD4 and Saline [p<0.02] ­compared to MKD4 and Saline 
[p<0.002]; (C) ³compared to SAL and MKD4 [p<0.005].  
 
3.4. Number of unique arms and time spent up to the 9  arm visit 
Overall ANOVA revealed significant differences between groups [F2,21= 62.83 and 50.75 
respectively, p<0.0001], between sessions [F6,126= 6.586 and 49.42 respectively, p<0.0001] 
and significant interactions between groups and sessions [F12,126= 2.60 and 6.72 
respectively, p<0.001]. Post-hoc comparisons show that MKD1 made significantly fewer unique 
arm visits in sessions 1 to 7 [p<0.04, Fig. 5A], and required less time to make these visits in 
sessions 2 to 7 [p<0.03, Fig. 5B] than SAL and MKD4.  
 
  
Figure 5. Number of unique arm visits (A) and time required to make 9 arm visits (B). All data 
are shown as means ± SEM; n=8 in each group. (A) ³compared to SAL and MKD4 
[p<0.0002]; ­compared to SAL [p<0.02] and to MKD4 [p<0.008]; hcompared to SAL 
[p<0.02] and to MKD4 [p<0.04]; (B) ³compared to SAL and MKD4 [p<0.03]; ­compared to 
SAL and MKD4 [p<0.0006].  
 
 
4. Discussion 
In the present study, C57 mice treated with dizocilpine from day 1 (MKD1) of the test 
demonstrated a very low number of arm entries in each test session compared to saline 
treated mice. They had also a high number of bridge entries, which led to a significantly low 
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arm bridge ratio in each test session. These results indicate that MK-801 treatment, which was 
started from day 1 of the test, produced anxiety in C57 mice and, this was maintained 
throughout the 7 sessions. 
The introduction of dizocilpine after 3 days of exposure to the maze under saline treatment 
(MKD4) produced a significant high number of bridge and arm entries compared to saline 
treated mice. This increase in bridge and arm entries reached a ratio close to 1 from session 5 
[group average 0.9 r0.04]. Saline treated mice also reached a comparable bridge/arm entries 
ratio, but this was achieved with a low number of arm entries [SAL 18.5 r1.2 vs MKD 37.4 
r4.1]. Treatment with dizocilpine from day 4 of the test did not produce anxiety; rather, it 
facilitated and increased significantly the number of crossings onto the arms. This does not 
imply that dizocilpine produced anxiolysis as MKD4 mice did show reduced anxiety before the 
start of the treatment; they made far more than 8 arm visits in the third session [Fig. 3A]. 
The present results seem to indicate that dizocilpine produced a psychomotor stimulation; 
this is more evident in MKD4 mice than in MKD1 mice. An increase in locomotor activity and 
impulsive response by dizocilpine, and other NMDA antagonists have been reported in the 
literature [Benn and Robinson 2014; Cottone et al., 2013; Fletcher et al., 2011; Gilmour  et 
al., 2009; Hauber 1993; Higgins et al., 2003; Martin et al., 1997; Paine et al., 2007; Paine and 
Carlezon  2009; Sanger and Joly 1991; Scorza et al., 2010]. Such an increase in locomotor 
activity may confound the effects of anxiolytic and anxiogenic drugs [Dawson et al., 1995; 
Sanger and Joly 1991; Weiss et al., 1998]. However, this cannot account for the anxiety level 
in MKD1 and MKD4 mice in the 3D maze. In MKD1, an increase in motor activity was limited to 
the bridges; it did not extend to the arms. In MKD4, anxiety was already low before the 
administration of MK-801, and it is unlikely that hyperactivity alone could have produced a 
consistent high number of unique arm visits in the first 9 arm choices. Hence, in MKD1 mice, 
the increase in bridge entries, though not as dramatic as the one shown with MKD4 mice, 
appears to be opposed by a high level of anxiety, which prevented mice from crossing onto the 
arms.  
MKD1 mice show a significant increase in entries and time spent in the arms, and a 
significant decrease in the latency of first arm visit in sessions 6 and 7 compared to the 
previous sessions. It seems likely that, with further exposures to the maze, the differences 
between MKD1 and saline treated mice would have been abolished or significantly reduced. In 
our previous study [Ennaceur et al., 2011], MK-801 treated C57BL/6J mice required 10 
sessions of exposures to the maze to reach a high number of arm entries comparable to that 
of saline treated mice. This suggests that the anxiogenic effect of dizocilpine is not long 
lasting. It may be overcome through habituation and leaning processes. 
The behavior of MKD1 mice contrasts with that of MKD4 mice, the latter demonstrated an 
increase in bridges and arm entries. MKD4 mice had already low basal level of anxiety at the 
start of the test, and with three pre-training session, it is unlikely that such level of anxiety 
could be decreased further. They were already moving freely in all parts of the maze with a 
group average of 15 arm entries and 0.62 arm/bridge entries ratio in session 3. MK-801 
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treatment seems to impair habituation in animals that were familiar with the test environment; 
it produced sustained non-habituating hyperactivity. This phenomenon have been reported for 
NMDA antagonists [Carey  et al., 1988; Klamer et al., 2004; Réus et al., 2008; Venâncio et al., 
2011] and genetic models of NMDA hypo-function [Ballard et al., 2002; Bickel et al., 2008; 
Duncan et al., 2006]. Hyperactivity and deficit in habituation were also observed in animals 
reared in social isolation [Geyer et al., 1990; 1993; Weiss et al., 2000; see Marsden 2011] and 
in dopamine transporter knockout mice [Zhuang et al 2001].  
It has been reported that a number of drugs produces behavioral sensitization, which 
refers to long-lasting and progressive enhancement of locomotor and motivational responses 
following repeated or intermittent administration of psychostimulant drugs [Kalivas and 
Stewart 1991]. Behavioral sensitization was demonstrated with psychostimulant drugs such as 
amphetamine [Pierce and Kalivas 1997; Segal and Mandell 1974; Stöhr et al 1998; Kuczenski 
and Segal 2001], cocaine [Carey et al., 1995; Miserendino and Nestler 1995; Post and Rose 
1976; Pierce and Kalivas 1997], methylphenidate [Crawford et al., 1998; Gaytan et al 1997; 
Kuczenski and Segal 2001], and also with dizocilpine [Vanderschuren et al 1997; Carey et al 
1995; Jessa et al 1996; Xu and Domino 1994a; Wedzony and Czyrak 1994; Wedzony et al 
1993; Wolf and Khansa 1991; Wolf et al 1993] and phencyclidine [Johnson et al 1998; Xu and 
Domino 1994b,c; Scalzo and Holson 1992]. The non-habituating hyperactivity observed in 
MKD4 seems to indicate that MK-801 induced progressive sensitization to its psychomotor 
stimulant effects. 
In MKD1 mice, the time spent in the bridges was higher and the time spent in the arms 
was lower than that of saline and MKD4 mice; the latter two groups were indistinguishable 
from one another. Both saline and the two MK-801 treated groups demonstrated a significant 
decrease between sessions in the time spent on the bridges, and an increase in the time spent 
on the arms. However, in MKD1 the arm/bridge time ratio reached 1 in the last test session, 
while in the other two groups it exceeded that ratio much earlier, in session 3. These results 
indicate that from session 3 onward, saline and MKD4 mice were no longer fearful to venture 
into and explore the arms. In session 3, saline and MKD4 mice spent more than 41% of the 
test session in the arms compared to 30% in the bridges, and in session 7 they spent more 
than 60% of the test session in the arms compared to 18% on the bridges. In MKD1 mice, the 
time spent in the arms in session 3 was 0.02% compared to 43% in the bridges, and in 
session 7 it was 26% in the arms and 24% on the bridges. 
Examination of the first 9 arm visits in each test session revealed that MKD1 made a high 
number of bridge entries (except in session 1), and made a very few unique arm visits 
compared to saline and MKD4.  The latter two groups were not different from each other; they 
demonstrated a significant increase in unique arm visits in sessions 4 to 7 compared to the 
first 3 sessions, which suggest a reduction in arm repeats. In MKD1 mice, these arm repeats 
were still high in the last test sessions, which suggests a slower acquisition of a win-shift 
strategy in this group compared to saline and MKD4 mice. The behavior of MKD1 mice is 
similar to that observed in our previous study in which C57BL/6J mice received MK-801 on day 
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1 of the acquisition of a working memory task [Ennaceur et al., 2011]. In this previous 
experiment, the number of arm visits [6.5 r1.4] and the number of unique arm visits [4.4 r1] 
in MK-801 treated mice were significantly low compared to that of saline [9 r0 and 7.1 r0.4, 
respectively] in session 7. 
The results of the present study add to a long-standing debate concerning the specific role 
of NMDA receptors in memory encoding [Cain et al., 1997; Caramanos and Shapiro 1994; 
Keith and Rudy 1990; Saucier and Cain 1995; Shapiro and Connor 1992]. NMDA receptors are 
considered essential to many of the activity-dependent changes in synaptic strength and 
connectivity, which are thought to underlie the formation of memory. Saucier et al. [1996] 
suggested that NMDA antagonists produce sensory-motor disturbances, which explain the 
memory encoding deficit observed in the water-maze. Non-spatial pre-training reduces the 
severity of these sensorimotor disturbances to the point where animals can acquire the task 
normally. Since then, numerous studies from these authors and others have been performed in 
various learning and memory paradigms; they demonstrated that familiarity with the test 
environment prevented the impairing effects of NMDA antagonists [Cain 1997; Caramanos and 
Shapiro1994; Chan and McNally 2009; Roesler et al., 1998; Shapiro and O'Connor 1992]. 
Hence, it appears that NMDA receptor-dependent synaptic plasticity is not necessary in all 
forms of learning. 
MK-801 at 1 and 0.05 mg/kg have been reported to induce alterations in both sensory 
processing and motor performance that interfere with learning [Ahlander et al., 1999; Ford  et 
al., 1989; Hargreaves and Cain 1992; Whishaw and Auer 1989]. In the present study, these 
sensory-motor disturbances were not apparent though our data revealed that pre-trained mice 
were hyperactive. It is possible that the wide range of motor disturbances observed with MK-
801 and other NMDA antagonists are specific to the water-maze and resulted from the high 
level of stress associated with this test [Aguilar-Valles et al., 2005; Harrison et al., 2009; 
Hölscher 1999; Patil et al., 2009]. In the radial maze and operant conditioning, hyperactivity is 
the most common nonspecific effect that has been reported [Clissold et al., 1991; Caramanos 
and Shapiro 1994]. The results of the present study indicate that MK-801 produces anxiety in 
the 3D maze, hence it is possible that a similar effect occurred with NMDA antagonists in the 
water-maze. Anxiety could account for the abnormal pattern of behavior described in the 
literature. When first placed in the maze, mice and rats try to find a way to escape before they 
discover that there is a platform hidden in the water that they can climb to take refuge. With 
an increase in anxiety, mice and rats may show high swimming activity, increased thigmotaxis 
or wall hugging, inability to climb onto and to remain on the platform. 
A number of studies reported that MK-801 and other NMDA antagonists exert anxiolytic 
effects in a number of anxiety tests [Clineschmidt  et al., 1982; Criswell et al., 1994; Dunn et 
al., 1989; Engin et al., 2009; Fraser et al., 1996; Jessa  et al., 1996; Kuribara  et al., 1990; 
Plaznik et al., 1994; Sharma and Kulkarni 1991; Soderpalm et al., 1995; Wieronska et al., 
2003; Xie and Commissaris 1992; see, Cryan and Dev 2008]. However, most of these studies 
reported an increase in motor activity indicating non-specific locomotor stimulation. 
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Furthermore, there are other studies which reported anxiogenic [Hetzler and Wautlet  1985; 
Ho et al., 2005; Mansbach et al., 1991; Mutlu et al., 2011; Rung et al., 2005; Silvestre et al., 
1997; Vasar et al., 1993; Wiley et al., 1998] or no effect [Criswell et al., 1994; Haj-Mirzaian et 
al., 2015; Hill et al., 2015; +OLĖiN DQG.UHMþÕɈ  Ho et al., 2005; Padovan et al., 2000; 
Sanger and Joly 1991; Trevlopoulou et al 2016] of NMDA antagonists. The above results were 
observed in a number of anxiety tests, the plus-maze in particular, which suffer major 
methodological flaws as discussed in our recent reviews [Ennaceur 2014; Ennaceur and Chazot 
2016].  
As indicated in the introduction, the 3D maze is a complete open space with no shelter or 
a wall against which animals can hide. Animals exposed for the first time to this maze 
demonstrate high level of exploration of the bridges (proximal segments); they climb 
frequently up to the far end of the bridges and withdraw with a few or no crossing onto the 
arms (distal segments). However, in subsequent sessions the number of crossings onto the 
arms does progressively increase though some strains of mice (e.g. BALB/cJ) requires more 
sessions than other strains (C57BL/6J and CD-1); the former are considered highly anxious 
than the latter [Ennaceur et al., 2006; Ennaceur 2011]. Hence, in the 3D maze, the effect of 
an anxiogenic intervention is expected to maintain, or increase and prolong anxiety over a 
large number of sessions, and the effect of an anxiolytic intervention is not expected to 
decrease with repeated exposures to the test. This behavioral profile of animals exposed to the 
3D maze differs considerably from that observed in the current tests of unconditioned anxiety. 
For instance, in the plus-maze, animals are reported to display an aversion of the open-arms 
on the first exposure to the maze and, this aversion is increased further in subsequent 
sessions [Arabo et al., 2014; Casarrubea et al., 2013; Espejo 1997; Holmes and Rodgers 
1998; Rosa et al., 2000; Treit et al., 1993]. In addition, a single previous experience of the 
plus-maze or light/dark box has been reported to reduce or abolish the effects of both 
anxiolytic and anxiogenic drugs [Dawson et al., 1994; Escarabajal et al., 2003; Holmes and 
Rodgers 2003; Rodgers and Shepherd 1993]. Hence, their lack of sensitivity makes it very 
difficult to predict the therapeutic potential of a drug, especially for chronic use, as it is 
possible that an initial reaction to a drug differs from its effects on subsequent uses [de Wit 
and Phillips 2012; Cole and Pieper 1973; Abuhamdah et al., 2015]. 
The present study suggests that dizocilpine produces anxiety and impairs habituation in a 
spatial navigation task in C57BL6/J mice that were unfamiliar but not in mice that were 
familiar with the test environment. Elevated anxiety and impaired habituation may account for 
the acquisition deficit reported in various learning and memory tests. 
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